Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07513168) titled 'Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults' on April 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Asian Institute Of Medical Sciences
Condition:
Obesity
Weight Reduction
Cardiometabolic Risk Factors
Intervention:
Drug: Locally available low-dose semaglutide (0.25 mg, 0.5 mg, 1 mg)...
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: August 1, 2025
Target Sample Size: 60
Countries of Recruitment:
Pakistan
To know mo...